Product Information

BUSPIRONE HCL 15 MG TABLET is a generic product labeled by Apnar Pharma LP, priced at $0.0423 per EA under NDC 24689092105. Its NADAC has been published 207 times since Mar 3, 2021.

FDA first approved this application on May 3, 2018. Its Orange Book therapeutic-equivalence code is BX.

BUSPIRONE HCL 15 MG TABLET

Buspirone Hydrochloride
$0.0423per EA

Strength

15 mg/1

Manufacturer

Apnar Pharma LP

NDC

24689092105

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

BUSPIRONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209696

FDA Approved

5/3/2018

TE Code

BX

On Market Since

6/17/2024

Price Statistics

The NADAC for BUSPIRONE HCL 15 MG TABLET has been published 207 times since Mar 3, 2021, and over the history we have for it it has declined 26.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0423 per EA
All-time high$0.0605 (May 12, 2021)
All-time low$0.0423 (Jul 22, 2026)
52-week high$0.0485
52-week low$0.0423
Median price$0.0485
Average price$0.0495
Largest weekly change-12.0% (Nov 23, 2022)
Weeks tracked207
Tracking sinceMar 3, 2021

Price History

1W

+0.0%

1M

+0.0%

3M

-1.5%

6M

-4.1%

1Y

-10.8%

3Y

-16.5%

5Y

-22.7%

All

-26.0%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of BUSPIRONE HCL 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 15 MG TABLET, manufactured by Apnar Pharma LP, is $0.0423 per EA (NDC 24689092105), effective Aug 19, 2026.

How has the price of BUSPIRONE HCL 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUSPIRONE HCL 15 MG TABLET has declined 26.0%. It has been tracked across 207 weekly CMS publications since Mar 3, 2021.

What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 15 MG TABLET?

Since Mar 3, 2021, the NADAC for BUSPIRONE HCL 15 MG TABLET has ranged from a low of $0.0423 (Jul 22, 2026) to a high of $0.0605 (May 12, 2021), with a median of $0.0485 per EA.

Are there cheaper alternatives to BUSPIRONE HCL 15 MG TABLET?

8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 15 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUSPIRONE HCL 15 MG TABLET?

BUSPIRONE HCL 15 MG TABLET (NDC 24689092105) is labeled by Apnar Pharma LP, and CMS classifies it as a generic product.